DaVita Inc
Change company Symbol lookup
Select an option...
DVA DaVita Inc
BBW Build-A-Bear Workshop Inc
GWPH GW Pharmaceuticals PLC
LMT Lockheed Martin Corp
TELL Tellurian Inc
PFE Pfizer Inc
AGNC Agnc Investment Corp
AAPL Apple Inc
GRTYA Guaranty Corp
SATS EchoStar Corp

Health Care : Health Care Providers & Services | Mid Cap Blend
Company profile

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.


Last Trade
0.00 (0.00%)
B/A Size

Market Hours

Closing Price
Day's Change
3.88 (3.68%)
B/A Size
Day's High
Day's Low

10-day average volume:



6 providers
November 23, 2020
14th Annual Tour DaVita Raises Nearly $1 Million for Bridge of Life

DaVita Inc. today announced its annual cycling event, Tour DaVita, raised nearly $1 million to benefit Bridge of Life, a nonprofit founded by DaVita that is focused on strengthening health care globally through sustainable programs that support the...(PR Newswire)

November 04, 2020
DaVita Responds to Proposition 23 in California

DaVita Kidney Care, a leading provider of kidney care services in the United States, issued the following statement: "We are grateful that Californians voted down Proposition 23, a harmful ballot measure that could have jeopardized access to...(PR Newswire)

October 29, 2020
DaVita Inc. 3rd Quarter 2020 Results

DaVita Inc. (NYSE: DVA) announced financial and operating results for the third quarter ended September 30, 2020. During the quarter, notwithstanding the challenges of responding to COVID-19, the Company delivered strong financial and operating...(PR Newswire)

DaVita, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 29, 2020 / DaVita, Inc. (SAO:DVAI34.SA) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on October 29, 2020 at 5:00 PM Eastern Time. (Accesswire)

October 22, 2020
DaVita Clinical Research to Present New Findings at American Society of Nephrology Kidney Week 2020

DaVita Clinical Research (DCR) will present 14 research abstracts from company representatives and medical professionals at the American Society of Nephrology (ASN) annual Kidney Week occurring Oct. 22-25, 2020. (PR Newswire)

October 15, 2020
DaVita Inc. Schedules 3rd Quarter 2020 Investor Conference Call

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2020, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same...(PR Newswire)

October 13, 2020
Chronic Diseases Tend To Lead To Kidney Failure, Thus An Increase Drives The Dialysis Devices And Equipment Market

(Dialysis Devices And Equipment Companies Included: Fresenius Medical Care AG & Co. KGaA, Baxter International, Nikkiso Co. Ltd, DaVita Inc., B. Braun Avitum AG, NxStage Medical, Asahi Kasei Corporation, Diaverum Deutschland GmbH, MEDIVATORS...(Globe Newswire)

September 24, 2020
Dialysis Devices And Equipment Global Market Report 2020-30: Covid 19 Impact and Recovery

Reportlinker.com announces the release of the report "Dialysis Devices And Equipment Global Market Report 2020-30: Covid 19 Impact and Recovery" - https://www.reportlinker.com/p05967817/?utm_source=GNW (Globe Newswire)

September 17, 2020
DaVita Announces Final Results Of Self-Tender Offer

DAVITA INC. (NYSE: DVA) ("DaVita") a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care services in the United States, announced today the final...(PR Newswire)

September 15, 2020
DaVita Announces Preliminary Results of Self-Tender Offer

DAVITA INC. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care services in the United States, announced today the...(PR Newswire)

September 11, 2020
Destination Pet Appoints Mike McArthur, Tom Chandler, and Alan Shackelford to Executive Team

Destination Pet today announced the appointment of three new executives to the leadership team. Mike McArthur has joined Destination Pet as its Chief Financial Officer, Thomas Chandler has joined as the Chief Legal Officer, and Alan Shackelford has...(PR Newswire)

September 10, 2020
Clinical Laboratory Services Market by 2027 Emerging Technology, Opportunities, Analysis and Future Threats with Key Players like DaVita Inc., Eurofins Scientific, UNILABS, SYNLAB International GmbH, MIRACA HOLDINGS Inc., Sonic Healthcare

Data Bridge Market Research has recently published the Global Research Report Titled Clinical Laboratory Services Market, This Clinical Laboratory Services Market report contains the company profiles, product specifications, capacity, production...(Globe Newswire)

September 08, 2020
DaVita Announces Shawn Guertin Will Join its Board of Directors

DaVita Inc. announced today that its Board of Directors appointed a new independent director, Mr. Shawn Guertin, to join the Board, effective Sept. 15. https://mma.prnewswire.com/media/398805/DAVITAjpg_Logo.jpg (PR Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.